SNP polymorphisms that have been known to affect the pharmacokinetic parameters of fluoroquinolone as an important drug in the treatment of MDR-TB are found in the UGT1A1, UGT1A9, SLCO1B1, and ABCB1 genes. Here, ABCB1 is linked to multidrug-resistant tuberculosis.